Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets

45Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Streptococcus pneumoniae is a serious human respiratory pathogen that has the capacity to evade capsule-based vaccines and to develop multidrug antibiotic resistance. This review summarizes recent advances in understanding the mechanisms and regulation of peptidoglycan (PG) biosynthesis that result in ellipsoid-shaped, ovococcus Streptococcus cells. New results support a two-state model for septal and peripheral PG synthesis at mid-cell, involvement of essential cell division proteins in PG remodeling, and mid-cell localization of proteins that organize PG biosynthesis and that form the protein translocation apparatus. PG biosynthesis proteins have already turned up as promising vaccine candidates and targets of antibiotics. Properties of several recently characterized proteins that mediate or regulate PG biosynthesis suggest a source of additional targets for therapies against pneumococcus. © 2012 Elsevier Ltd.

Cite

CITATION STYLE

APA

Sham, L. T., Tsui, H. C. T., Land, A. D., Barendt, S. M., & Winkler, M. E. (2012, April). Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets. Current Opinion in Microbiology. https://doi.org/10.1016/j.mib.2011.12.013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free